We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock
ARAV

Delisted

ARAV was delisted on the 26th of January, 2024.

Back to rankings

31 hedge funds and large institutions have $26.2M invested in Aravive, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more call options, than puts

Call options by funds: $168K | Put options by funds: $105K

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

36% more capital invested

Capital invested by funds: $19.2M → $26.2M (+$6.98M)

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

3% more funds holding

Funds holding: 30 → 31 (+1)

Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
9
Reduced
7
Closed
2
Calls
$168K
Puts
$105K
Net Calls
+$63K
Net Calls Change
-$65K

Top Buyers

1
BBA
Baker Bros. Advisors
New York
+$1.12M
2
AG
Artal Group
Luxembourg
+$577K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$197K
4
Renaissance Technologies
Renaissance Technologies
New York
+$152K
5
Morgan Stanley
Morgan Stanley
New York
+$49.3K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$208K
2
PAM
Panagora Asset Management
Massachusetts
-$40.6K
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$29K
4
UBS Group
UBS Group
Switzerland
-$10.7K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$4.99K
Name Holding Trade Value Shares
Change 		Change in
Stake
NLVP
1
New Leaf Venture Partners
New York
$7.28M – – –
BBA
2
Baker Bros. Advisors
New York
$4.98M +$1.12M +179,141 +37%
SB
3
Samsara BioCapital
California
$3.32M – – –
AG
4
Artal Group
Luxembourg
$3M +$577K +92,534 +30%
BlackRock
5
BlackRock
New York
$1.3M -$4.06K -652 -0.4%
Renaissance Technologies
6
Renaissance Technologies
New York
$1.29M +$152K +24,394 +16%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$1.26M +$13K +2,080 +1%
BOTOTLSJU
8
Board of Trustees of The Leland Stanford Junior University
California
$1.1M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$942K -$208K -33,339 -21%
UBS Group
10
UBS Group
Switzerland
$495K -$10.7K -1,714 -3%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$237K +$197K +31,559 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$226K -$898 -144 -0.5%
BCM
13
Bridgeway Capital Management
Texas
$165K – – –
Morgan Stanley
14
Morgan Stanley
New York
$140K +$49.3K +7,913 +74%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$122K -$4.99K -800 -5%
Northern Trust
16
Northern Trust
Illinois
$118K – – –
Bank of New York Mellon
17
Bank of New York Mellon
New York
$101K – – –
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$41K – – –
Victory Capital Management
19
Victory Capital Management
Texas
$10K +$8.39K +1,346 New
MAM
20
Meeder Asset Management
Ohio
$8K +$6 +1 +0.1%
PAM
21
Panagora Asset Management
Massachusetts
$4K -$40.6K -6,511 -92%
Bank of America
22
Bank of America
North Carolina
$4K +$3.45K +553 +838%
Wells Fargo
23
Wells Fargo
California
$2K -$561 -90 -28%
TRCT
24
Tower Research Capital (TRC)
New York
$2K +$1.23K +198 +825%
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$1.06K – – –
1
2

ARAV Hedge Fund Activity: Q3 2019 in Review

31 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q3 2019, worth a combined $26.2M — up 36% from $19.2M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ARAV positions and 2 closed out — a net gain of 1 holder — while 9 added to existing stakes and 7 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $1.12M. The largest seller was Vanguard Group, cutting an estimated $208K.

  • 31 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q3 2019, up from 30 in Q2 2019.
  • Funds reported $26.2M of Aravive, Inc. Common Stock stock for Q3 2019, up 36% quarter-over-quarter.
  • 3 funds opened new Aravive, Inc. Common Stock positions in Q3 2019 and 2 closed out, a net change of +1 holder.
  • The largest Aravive, Inc. Common Stock buyer in Q3 2019 was Baker Bros. Advisors, an estimated $1.12M added.
  • The largest Aravive, Inc. Common Stock seller in Q3 2019 was Vanguard Group, an estimated $208K sold.

Based on aggregated 13F filings for Q3 2019.